Zobrazeno 1 - 10
of 351
pro vyhledávání: '"Novero D"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Agnelli L., Mereu E., Pellegrino E., Limongi T., Kwee I., Bergaggio E., Ponzoni M., Zamò A., Iqbal J., Neri A., Chan W. C., Bertoni F., Inghirami G., Piva R., European T. Cell Lymphoma Study G.r.o.u.p. Barreca A., Cuccuru G., Medico E., Spaccarotella E., Scarfò I., Fornari A., Ferreri C., Novero D., Chilosi M., Facchetti F., Lonardi S., De Chiara A., Fulciniti F., Doglioni C., Todoerti K., Falini B., Tiacci E., Van Loo P., Tousseyn T., De Wolf Peeters C., Geissinger E., Muller Hermelink H. K., Rosenwald A., Piris M. A., Rodriguez M. E., Boi M., PICCALUGA, PIER PAOLO, PILERI, STEFANO, AGOSTINELLI, CLAUDIO
Publikováno v:
Blood. 120:1274-1281
Anaplastic large-cell lymphomas (ALCLs) are a group of clinically and biologically heterogeneous diseases including the ALK(+) and ALK(-) systemic forms. Whereas ALK(+) ALCLs are molecularly characterized and can be readily diagnosed, specific immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d633c086f5cb4a0db2a4e8dd3073f1b3
https://doi.org/10.1182/blood-2012-01-405555
https://doi.org/10.1182/blood-2012-01-405555
Autor:
Tarella, Corrado, Zanni, M, DI NICOLA, M, Patti, C, Calvi, R, Pescarollo, A, Zoli, V, Fornari, A, Novero, D, Cabras, A, Stella, M, Comino, A, Remotti, D, Ponzoni, M, Caracciolo, D, Ladetto, Marco, Magni, M, Devizzi, L, Rosato, Rosalba, Boccadoro, Mario, Bregni, M, Corradini, P, Gallamini, A, Majolino, I, Mirto, S, Gianni, Am, GRUPPO ITALIANO TERAPIE INNOVATIVE NEI LINFOMI
Publikováno v:
Leukemia. 21:1802-1811
A prospective multicenter program was performed to evaluate the combination of rituximab and high-dose (hd) sequential chemotherapy delivered with multiple autologous peripheral blood progenitor cell (PBPC) support (R-HDS-maps regimen) in previously
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaaae512e807c04c5c174d51f21bdd4f
https://doi.org/10.1038/sj.leu.2404781
https://doi.org/10.1038/sj.leu.2404781
Autor:
ANNALISA CHIAPPELLA, Agostinelli, C., Martelli, M., Righi, S., Evangelista, A., Novero, D., Gotti, M., Carella, A. M., Stelitano, C., Tucci, A., Cabras, M. G., Balzarotti, M., Gaidano, G., Ladetto, M., Pileri, S. A., Vitolo, U.
Publikováno v:
Publons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2071002e559bb0b1feb29f0a575a169e
http://hdl.handle.net/11585/633333
http://hdl.handle.net/11585/633333
Autor:
Crescenzo, R., Abate, F., Lasorsa, E., Tabbo', F., Gaudiano, M., Chiesa, N., Di Giacomo, F., Spaccarotella, E., Barbarossa, L., Ercole, E., Todaro, M., Boi, M., Acquaviva, A., Ficarra, E., Novero, D., Rinaldi, A., Tousseyn, T., Rosenwald, A., Kenner, L., Cerroni, L., Tzankov, A., Ponzoni, M., Paulli, M., Weisenburger, D., Chan, W. C., Iqbal, J., Piris, M. A., Zamo', A., Ciardullo, C., Rossi, D., Gaidano, G., Pileri, S., Tiacci, E., Falini, B., Shultz, L. D., Mevellec, L., Vialard, J. E., Piva, R., Bertoni, F., Rabadan, R., Inghirami, G.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3674::4fe7c61a2276fc8a3ba0415b0f01b6d4
https://hdl.handle.net/11380/1281686
https://hdl.handle.net/11380/1281686
Autor:
Franco, Vito, Ascani, S., Asioli, S., Boveri, E., Gambacorta, M., Gianelli, U., Goteri, G., Lo Bosco G., Lucioni, M., Maiorana, A., Novero, D., Schena, C., Sirotti, M., Claudio Tripodo, Paulli, M.
Publikováno v:
Università degli Studi di Palermo-IRIS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2494fa4d622bea9d4610f83b581853ea
http://hdl.handle.net/10447/59495
http://hdl.handle.net/10447/59495
Autor:
Vitolo, U, Chiappella, A, Angelucci, E, Rossi, G, Liberati, Anna Marina, Cabras, Mg, Botto, B, Ciccone, G, Gaidano, G, Falchi, L, Freilone, R, Novero, D, Orsucci, L, Pavone, V, Pogliani, E, Rota Scalabrini, D, Salvi, F, Tonso, A, Tucci, A, Levis, A, Leucemie, Gruppo Italiano Multiregionale Linfomi e.
Background We investigated the addition of rituximab to dose-dense and high-dose chemotherapy with autologous stem cell transplantation in patients with untreated poor-prognosis diffuse large B-cell lymphoma.Design and Methods Ninety-four young patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b604a8ed4dc5d73d04d27b4ec17d03ca
http://hdl.handle.net/10281/20853
http://hdl.handle.net/10281/20853
Autor:
Arcaini, L, Lazzarino, M, Colombo, N, Burcheri, S, Boveri, E, Paulli, M, Morra, E, Gambacorta, M, Cortelazzo, S, Tucci, A, Ungari, M, Ambrosetti, A, Menestrina, F, Orsucci, L, Novero, D, Pulsoni, A, Frezzato, M, Gaidano, G, Vallisa, D, Minardi, V, Tripodo, C, Callea, V, Baldini, L, Merli, F, Federico, Massimo, Franco, V, Iannitto, E, INTEGRUPPO ITALIANO LINFOMI
The Integruppo Italiano Linfomi (IIL) carried out a study to assess the outcomes of splenic marginal zone lymphoma and to identify prognostic factors in 309 patients. The 5-year cause-specific survival (CSS) rate was 76%. In univariate analysis, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00bac53573dda9154889da21834af84e
http://www.bloodjournal.org/cgi/reprint/107/12/4643
http://www.bloodjournal.org/cgi/reprint/107/12/4643